Scarica l'app Stockscreener
22.25
0.80%
-0.18
Dopo l'orario di chiusura:
22.25
Pacira Biosciences Inc Borsa (PCRX) Ultime notizie
What drives Pacira BioSciences Inc. stock priceLightning-fast growth - Autocar Professional
Pacira BioSciences Inc. Stock Analysis and ForecastMarket-crushing stock picks - jammulinksnews.com
Pacira, JNJ in pact to boost Zilretta availability (PCRX) - Seeking Alpha
Pacira BioSciences Announces Strategic Collaboration to Significantly Expand ZILRETTA Promotional Efforts - The Manila Times
Major Expansion: J&J to Co-Promote Pacira's ZILRETTA Across 7M Annual Knee Injections Market - Stock Titan
Bank of New York Mellon Corp Decreases Stock Position in Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World
What analysts say about Pacira BioSciences Inc. stockFree Stock Market Return Analysis - Autocar Professional
Is Pacira BioSciences Inc. a good long term investmentGame-changing capital returns - Autocar Professional
Zacks Research Has Negative Estimate for PCRX Q4 Earnings - Defense World
Teacher Retirement System of Texas Lowers Position in Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World
Further Weakness as Pacira BioSciences (NASDAQ:PCRX) Drops 5.9% This Week, Taking Three-year Losses to 60% - 富途牛牛
Shareholders in Pacira BioSciences (NASDAQ:PCRX) have lost 60%, as stock drops 5.9% this past week - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pacira BioSciences, Inc. (PCRA) And Encourages Shareholders to Reach Out - ACCESS Newswire
Why Pacira BioSciences Inc. stock attracts strong analyst attentionFree Expert-Led Investment Training - Newser
Pacira BioSciences Investors: Know Your Rights Amid Lawsuit - AInvest
Investors who lost money with shares of Pacira BioSciences, Inc. (NASDAQ: PCRX) should contact the Shareholders Foundation in connection with Lawsuit - PR Newswire
Principal Financial Group Inc. Increases Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World
Brokerages Set Pacira BioSciences, Inc. (NASDAQ:PCRX) Target Price at $26.44 - Defense World
Pacira BioSciences announces workforce reduction and facility changes By Investing.com - Investing.com Nigeria
Finance Watch: Karyopharm Cuts Jobs In Cash Crunch; Pacira’s Layoffs Attributed To Efficiency - insights.citeline.com
What makes Pacira BioSciences Inc. stock price move sharplyFree Real-Time Stock Data - Newser
Pacira announces layoffs due to efficiencies in Exparel production - MSN
Pacira BioSciences Gene Therapy Shows Sustained Knee Osteoarthritis Improvement - MSN
Allspring Global Investments Holdings LLC Makes New $277,000 Investment in Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World
Pacira BioSciences (PCRX) Plunges 3.33% Amid Restructuring - AInvest
Pacira Pharmaceuticals Implements Workforce Reduction for Efficiency - The Globe and Mail
Bronstein, Gewirtz & Grossman, LLC Is Investigating Pacira BioSciences, Inc. (PCRA) And Encourages Investors to Connect - ACCESS Newswire
Pacira BioSciences announces workforce reduction and facility changes - Investing.com Australia
Pacira stock slips amid layoffs in U.S. (PCRX:NASDAQ) - Seeking Alpha
Pacira BioSciences announces workforce reduction - MarketScreener
GAMMA Investing LLC Increases Stock Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World
Bronstein, Gewirtz & Grossman, LLC Encourages Pacira BioSciences, Inc. (PCRA) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Pacira Pharmaceuticals Secures New $300M Credit Facility - The Globe and Mail
Murano (MRNO) targets $500M for Bitcoin Treasury via new SEPA | PCRX SEC FilingForm 8-K - Stock Titan
Where are the Opportunities in (PCRX) - news.stocktradersdaily.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pacira BioSciences, Inc. (PCRA) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pacira BioSciences, Inc. (PCRA) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Pacira Issues Major Stock Compensation Package: 15,800 Shares Granted to New Executives - Stock Titan
Pacira BioSciences: Equity Incentives Fueling Long-Term Growth in Non-Opioid Pain Management - AInvest
PCRX ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Pacira BioSciences, Inc. - ACCESS Newswire
State of Alaska Department of Revenue Has $635,000 Stock Position in Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World
Upper Peninsula ABC 10News, Sports, Weather and More from Michigan's Upper Peninsula - FinancialContent
1.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):